Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer

Fig. 3

Circulating UCA1-containing exosomes predict the clinical outcome of cetuximab therapy in CRC patients. a The quantity of exosomes was higher in PD/SD patients (n = 23) than in PR/CR patients (n = 30), but this difference was not significant. b qRT-PCR assays showed a higher UCA1 expression in circulating serum exosomes in PD/SD patients than in those in PR/CR patients (p < 0.01)

Back to article page